[Present status in the development of new antineoplastic agents].
Since the end of the seventies in the development of anti-tumourous chemotherapeutic agents a certain stagnation can be observed. Only few new cytostatics were introduced into clinical practice. Although the last few years were not characterized by a basically new drug with an anti-tumourous effect, the range of cytostatics used was enriched by a major number of new cytostatics. Most of them are derivatives of drugs which proved useful in practice and which were prepared in order to enhance the anti-tumourous effect or to reduce the toxicity. The author summarizes information on these new cytostatics and initial clinical experience assembled with these drugs.